Naltrexone utility in depressed alcoholics

Psychopharmacology Bulletin

Volumn 34, Issue 1, 1998, Pages 111-115

  Salloum, Ihsan M ^a   Cornelius, Jack R ^b   Thase, Michael E ^b   Daley, Dennis C ^b   Kirisci, Levent ^b   Spotts, Crystal ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE

Author keywords

Depressed alcoholics; Dual diagnosis; Naltrexone; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BUSPIRONE; COCAINE; FLUOXETINE; NALTREXONE; NEFAZODONE; OPIATE ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DRINKING BEHAVIOR; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NAUSEA; NERVOUSNESS; PRIORITY JOURNAL; SUBSTANCE ABUSE; URINE INCONTINENCE;

ADULT; ALCOHOLISM; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PILOT PROJECTS;

EID: 0031902430     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: The Association, 1994.
2. Beck, AT; Ward, CH; Mendelson, M; Mock, J; and Erbaugh, JK. An inventory for measuring depression. Arch. Gen. Psychiatry 4:561-571, 1961.
3. Cornelius, JR; Salloum, IM; Ehler, JG; Jarrett, PJ; Cornelius, MD; Perel, JM; Thase, ME; and Black, A. Fluoxetine in depressed alcoholics: A double-blind placebo-controlled trial. Arch. Gen. Psychiatry 54(8):700-705, 1997.
4. Cornelius, JR; Salloum, IM; Mezzich, J; Cornelius, MD; Fabrega, H; Ehler, JG; Ulrich, RF; Thase, ME; and Mann, JJ. Disproportionate suicidality in patients with comorbid major depression and alcoholism. Am. J. Psychiatry 152:358-364, 1995.
5. Crowley, TJ; Wagner, JE; Zerbe, G; and MacDonald, MJ. Naltrexone-induced dysphoria in former opioid addicts. Am. J. Psychiatry 142:1081-1084, 1985.
6. Endicott, J; Spitzer, RL; Fleiss, JL; and Cohen, J. The Global Assessment Scale. Arch. Gen. Psychiatry 33:767-771, 1976.
7. First, MB; Spitzer, RL; Gibbon, M; and Williams, JBW. Structured Clinical Interview for DSM-IV - Patient Edition (SCID-P, Version 2.0). New York, NY: Biometrics Research Department, New York State Psychiatric Institute, 1994.
8. Fuller, RK; Branchey, L; Brightwell, DR; Derman, RM; Emrick, CD; Iber, FL; James, KE; Lacoursiere, RB; Lee, KK; Lowenstan, I; Maany, I; Neiderhiser, D; Nocks, JJ; and Shaw, S. Disulfiram treatment of alcoholism. JAMA 256:1449-1455, 1986.
9. Gibbons, JE. Nonparametric Method for Quantitative Analysis, 3d ed. Columbus, OH: American Science Press, Inc., 1997.
10. Guy, W. ECDEU Assessment Manual for Psychopharmacology, revised. DHEW Pub. No. (ADM)76-338. Rockville, MD: National Institute of Mental Health, 1976.
11. Hamilton, M. A psychiatric rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23:56-62, 1960.
12. Handelsman, L; Aronson, MJ; Ness, R; Cochrane, KJ; and Kanof, PD. The dysphoria of heroin addiction. Am. J. Drug Alcohol Abuse 18:275-287, 1992.
13. Helzer, JE, and Pryzbeck, TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J. Stud. Alcohol 49:219-224, 1988.
14. Hesselbrock, MN; Meyer, RE; and Keener, JJ. Psychopathology in hospitalized alcoholics. Arch. Gen. Psychiatry 42:1050-1055, 1985.
15. Kranzler, HR; Burleson, JA; Korner, P; Del Boca, FK; Bohn, MJ; Brown, J; and Liebowitz, N. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am. J. Psychiatry 152:391-397, 1995.
16. Mason, BJ; Kocsis, JH; Ritvo, CE; and Cutler, RB. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 275:761-767, 1996.
17. McLellan, AT; Luborsky, L; Woody, GE; and O'Brien, CP. An improved evaluation instrument for alcohol and drug abuse patients. J. Nerv. Ment. Dis. 163:26-33, 1980.
18. O'Malley, SS; Jaffe, AJ; Chang, G; Schottenfeld, RS; Meyer, RE; and Rounsaville, B. Naltrexone and coping skills therapy for alcohol dependence. Arch. Gen. Psychiatry 49:881-887, 1992.
19. Regier, DA; Farmer, ME; Rae, DS; Locke, BZ; Keith, SJ; Judd, LL; and Goodwin, FK. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. JAMA 264:2511-2518, 1990.
20. Ross, HE; Glaser, FB; and Germanson, T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch. Gen. Psychiatry 45:1023-1031, 1988.
21. Salloum, IM, and Cornelius, JR. Management of side effects of drugs used in treatment of alcoholism and drug abuse. In: Balon, R, ed. Practical Management of Psychotropic Drug Side Effects. New York: Marcel Dekker, Inc., in press.
22. Salloum, IM; Mezzich, JE; Cornelius, JR; Day, NL; Daley, D; and Kirisci, L. Clinical profile of comorbid major depression and alcohol use in an initial psychiatric evaluation. Compr. Psychiatry 36:260-266, 1995.
23. Schuckit, MA; Tip, JE; Bergman, M; Reich, W; Hesselbrock, VM; and Smith, TL. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am. J. Psychiatry 154:948-957, 1997.
24. Sobell, LC; Sobell, MB; Leo, GI; and Cancilla, A. Reliability of a timeline method: Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br. J. Addict. 83:393-402, 1988.
25. Sullivan, JT; Sykora, K; Schneiderman, J; Narango, CA; and Sellers, EM. Assessment of alcohol withdrawal: The revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar). Br. J. Addict. 84:1353-1357, 1989.
26. Terenius, L; Wahlstrom, A; and Aoren, H. Naloxone (Narcan) treatment in depression: Clinical observations and effects on CSF endorphins and monoamine metabolites. Psychopharmacology 54:31-33, 1977.
27. Volpicelli, JR; Alterman, AI; Hayashida, M; and O'Brien, CP. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry 49:876-880, 1992.
28. Weiss, RD; Griffin, ML; and Hufford, C. Craving in hospitalized cocaine abusers as a predictor of outcome. Am. J. Drug Alcohol Abuse 21:289-301, 1995.